Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflection: Axillary Dissection for Negative Lymph Nodes in Inflammatory Breast Cancer—Need for Clinical Trials to Reassess Standard of Care

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Network NCC. Breast Cancer (Version 4.2020). 2020. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 13 July 2020.

  2. Caudle AS, Bedrosian I, Milton DR, et al. Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons Members. Ann Surg Oncol. 2017;24(10):2925–34.

    Article  Google Scholar 

  3. Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072–8.

    Article  CAS  Google Scholar 

  4. DeSnyder SM, Mittendorf EA, Le-Petross C, et al. Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer. Clin Breast Cancer. 2018;18(1):e73–7.

    Article  Google Scholar 

  5. Lauren M. Postlewait MT, Sarah M. DeSnyder, Bora Lim, Wendy A.Woodward, Naoto T. Ueno, Anthony Lucci. Contralateral axillary metastases in patients with inflammatory breast cancer. Ann Surg Oncol. 2020. (in Press).

  6. Postlewait LM, Teshome M, DeSnyder SM, et al. Factors associated with pathological node negativity in inflammatory breast cancer: Are there patients who may be candidates for a de-escalation of axillary surgery? Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08891-y.

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Lauren M. Postlewait MD & Anthony Lucci MD, FACS

  2. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Anthony Lucci MD, FACS

Authors
  1. Lauren M. Postlewait MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Lucci MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Lucci MD, FACS.

Ethics declarations

Disclosures

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Postlewait, L.M., Lucci, A. ASO Author Reflection: Axillary Dissection for Negative Lymph Nodes in Inflammatory Breast Cancer—Need for Clinical Trials to Reassess Standard of Care. Ann Surg Oncol 27 (Suppl 3), 676–677 (2020). https://doi.org/10.1245/s10434-020-08952-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08952-2

Search

Navigation